ACE Cash Express and Netspend Raised $593,300 for the National Breast Cancer Foundation kdhnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kdhnews.com Daily Mail and Mail on Sunday newspapers.
Share
A team of researchers from Monash University has discovered that a cardiac drug (carvedilol) could greatly reduce breast cancer progression, with those taking the drug at the time of diagnosis also much more likely to survive.
Carvedilol is a beta-blocker used to manage cardiovascular disorders including hypertension and chemotherapy induced heart disease.
In collaboration with a team from the Cancer Registry of Norway, the researchers investigated the effects of carvedilol in a large cohort of breast cancer patients (4,014) and found that if women happened to be taking carvedilol when they were diagnosed, they had a greater chance of survival than those not taking the drug.
An improved high-tech fluorescence microscopy technique is allowing researchers to film cells inside the breast as never seen before.
This new protocol provides detailed instructions on how to capture hi-res movies of cell movement, division and cooperation, in hard-to-reach regions of breast tissue.
The technology - called multiphoton microscopy - uses infrared lasers to illuminate fluorescently labelled breast cells without harming them, so that elusive cell behaviours can be observed within living tissue.
Global Anticancer Drugs Market 2021 COVID-19 Impact, Key Players, Trends, Sales, Supply, Analysis and Forecast 2027 sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.